Search

Your search keyword '"Berney, Daniel M."' showing total 684 results

Search Constraints

Start Over You searched for: Author "Berney, Daniel M." Remove constraint Author: "Berney, Daniel M."
684 results on '"Berney, Daniel M."'

Search Results

205. Abstract 3878: The different genetic alterations between Western and Chinese samples indicate alternate pathways of prostate cancer development

209. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

210. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes

211. Absolute Quantitation of DNA Methylation of 28 Candidate Genes in Prostate Cancer Using Pyrosequencing

214. CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other human cancers

215. Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer

216. Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

217. The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers

219. Abstract 662: Molecular characterisation of ERG, ETV-1 and PTEN- gene loci identifies patients at low and high risk of death from prostate cancer

221. Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours

224. Clinical manifestations of familial paraganglioma and phaeochromocytomas insuccinate dehydrogenase B(SDH-B) gene mutation carriers

225. Nomogram incorporating PSA level to predict cancer‐specific survival for men with clinically localized prostate cancer managed without curative intent

226. Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists.

231. Fumarate Hydratase–deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate HydrataseMutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome

235. Tumors of the Testis

236. Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively.

237. The retinoblastoma protein/p16.

238. Histological sampling protocols for transurethral resection of prostate specimens need reappraisal.

239. Update on testis tumours

240. The Association of CCND1Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers

241. Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts.

242. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours.

243. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors.

244. WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.

245. Evolution not revolution.

246. Phospholipase D2 in prostate cancer: protein expression changes with Gleason score.

247. Sex differences in oncogenic mutational processes

248. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

249. Acromegaly and Cushing's syndrome caused by a neuroendocrine tumor arising within a sacrococcygeal teratoma

250. Sex differences in oncogenic mutational processes

Catalog

Books, media, physical & digital resources